Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FEDERAL SIGNAL CORP /DE/FSS · Entity 3709 | Director | April 21, 2026 | April 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FEDERAL SIGNAL CORP /DE/
Report date April 21, 2026 · Filed April 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,734 |
Reported balance
After 2026-04-21 transaction · row 1
1 source rowRow 1 · 2026-04-21 · Grant · Acquired 1,277 · Balance 58,734 |
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AGILITI, INC. \DE
Report date May 07, 2024 · Filed May 07, 2024
Section 16 reporting ended · disclosed 2024-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-05-07 transaction · row 1
1 source rowRow 1 · 2024-05-07 · Disposition to issuer · Disposed 39,401 · Balance 0 F1: On May 7, 2024 (the "Closing Date"), Agiliti, Inc. (the "Company"), completed its merger (the "Merger") with Apex Intermediate Holdco, Inc., ("Parent"), and Apex Merger Sub, Inc., and a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms and conditions of the Merger Agreement and Plan of Merger, dated as of February 26, 2024, by and among the Company, Parent and Merger Sub (the "Merger Agreement") at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive $10.00 per share in cash, without interest. |
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.13 · Expires 2024-11-04 | Direct | 0 |
Reported balance
After 2024-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-07 · Disposition to issuer · Disposed 27,653 · Balance 0 F2: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. |
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.27 · Expires 2029-03-06 | Direct | 0 |
Reported balance
After 2024-05-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-07 · Disposition to issuer · Disposed 55,703 · Balance 0 F2: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. |
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.25 · Expires 2030-03-06 | Direct | 0 |
Reported balance
After 2024-05-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-05-07 · Disposition to issuer · Disposed 50,909 · Balance 0 F2: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 7, 2024 (the "Closing Date"), Agiliti, Inc. (the "Company"), completed its merger (the "Merger") with Apex Intermediate Holdco, Inc., ("Parent"), and Apex Merger Sub, Inc., and a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms and conditions of the Merger Agreement and Plan of Merger, dated as of February 26, 2024, by and among the Company, Parent and Merger Sub (the "Merger Agreement") at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive $10.00 per share in cash, without interest.
F2: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option.
CONMED Corp
Report date May 20, 2025 · Filed May 21, 2025
Section 16 reporting ended · disclosed 2025-05-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,891 |
Reported balance
After 2025-05-20 transaction · row 1
1 source rowRow 1 · 2025-05-20 · Exercise / conversion · Acquired 479 · Balance 20,891 |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2034-06-03 | Direct | 0 |
Reported balance
After 2025-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-20 · Exercise / conversion · Disposed 479 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
Care Capital Properties, Inc.
Report date August 17, 2017 · Filed August 18, 2017
Section 16 reporting ended · disclosed 2017-08-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-17 transaction · row 1
1 source rowRow 1 · 2017-08-17 · Disposition to issuer · Disposed 26,626 · Balance 0 F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra, Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, each outstanding share of the Issuer's common stock on August 17, 2017 was exchanged for the right to receive 1.123 newly issued shares of Sabra's common stock, subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger, dated May 7, 2017 (the "Merger Agreement"), by and among Sabra Health Care REIT, Inc., a Maryland corporation ("Sabra"), Sabra Health Care Limited Partnership, a Delaware limited partnership, PR Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of Sabra, Care Capital Properties, Inc., a Delaware corporation (the "Issuer"), and Care Capital Properties, LP, a Delaware limited partnership, each outstanding share of the Issuer's common stock on August 17, 2017 was exchanged for the right to receive 1.123 newly issued shares of Sabra's common stock, subject to certain adjustments as set forth in the Merger Agreement. The closing price of shares of Sabra's common stock on August 16, 2017 was $21.72 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2026 Filed Apr 23, 2026 18:12 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 1,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-026782 · wk-form4_1776967939.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,734 Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 22:33 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-051716 · wk-form4_1762986784.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,457 F1 · shares: The shares were disposed of in connection with a bona fide gift by the Reporting Person. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015194 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 479 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 479 | $59.84 | $28,663.36 |
DisclosureSEC source: 0001127602-25-015194 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2025 Filed Apr 23, 2025 17:19 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 1,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001923233-25-000040 · wk-form4_1745428767.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,957 Read SEC document |
| December 11, 2024 Filed Dec 12, 2024 01:53 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001923233-24-000052 · wk-form4_1733968377.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,988 F1 · shares: The shares were disposed of in connection with a bona fide gift by the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:12 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 01:12 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 01:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017851 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2024 Filed May 7, 2024 14:33 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | Disposition to issuerOptions (Right to Buy) · Derivative | 50,909 | Not disclosed Strike: $8.25 | Not disclosed |
DisclosureSEC source: 0001415889-24-012418 · form4-05072024_020537.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 50,909 shares Expires 2030-03-06 F2 · security: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. F2 · price: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. Read SEC document |
| May 07, 2024 Filed May 7, 2024 14:33 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | Disposition to issuerOptions (Right to Buy) · Derivative | 55,703 | Not disclosed Strike: $6.27 | Not disclosed |
DisclosureSEC source: 0001415889-24-012418 · form4-05072024_020537.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 55,703 shares Expires 2029-03-06 F2 · security: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. F2 · price: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. Read SEC document |
| May 07, 2024 Filed May 7, 2024 14:33 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | Disposition to issuerOptions (Right to Buy) · Derivative | 27,653 | Not disclosed Strike: $2.13 | Not disclosed |
DisclosureSEC source: 0001415889-24-012418 · form4-05072024_020537.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.0001 par value · 27,653 shares Expires 2024-11-04 F2 · security: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. F2 · price: Subject to the terms and conditions of the Merger Agreement, at the Effective Time, each of the reporting person's outstanding and unexercised options to purchase shares of Common Stock (an "Option"), whether vested or unvested, were terminated and cancelled for the right to receive a lump sum cash payment, without interest thereon and subject to applicable withholding taxes, equal to (A) the number of shares of Common Stock underlying the Option immediately prior to the Effective Time, multiplied by (B) an amount equal to the amount that $10.00 exceeded the applicable exercise price of the Option. Read SEC document |
| May 07, 2024 Filed May 7, 2024 14:33 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | Disposition to issuerCommon Stock, $0.0001 par value | 39,401 | $10.00 | $394,010.00 |
DisclosureSEC source: 0001415889-24-012418 · form4-05072024_020537.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: On May 7, 2024 (the "Closing Date"), Agiliti, Inc. (the "Company"), completed its merger (the "Merger") with Apex Intermediate Holdco, Inc., ("Parent"), and Apex Merger Sub, Inc., and a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms and conditions of the Merger Agreement and Plan of Merger, dated as of February 26, 2024, by and among the Company, Parent and Merger Sub (the "Merger Agreement") at the Effective Time (as defined in the Merger Agreement), each of the reporting person's shares of Company common stock issued and outstanding immediately prior to the Effective Time was converted into the right to receive $10.00 per share in cash, without interest. Read SEC document |
| April 23, 2024 Filed Apr 23, 2024 23:24 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 1,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001923233-24-000020 · wk-form4_1713914641.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,988 Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 23:37 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | Exercise / conversionStock Option (right-to-buy) · Derivative | 5,000 | $0.00 Strike: $12.69 | $0.00 |
DisclosureSEC source: 0001923233-23-000083 · wk-form4_1701905860.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options became exercisable as to all 5,000 shares on 2/20/2017. Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 23:37 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | Tax withholdingCommon Stock | 913 | $69.50 | $63,453.50 |
DisclosureSEC source: 0001923233-23-000083 · wk-form4_1701905860.xml · nonDerivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,495 Read SEC document |
| December 06, 2023 Filed Dec 6, 2023 23:37 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | Exercise / conversionCommon Stock | 5,000 | $12.69 | $63,450.00 |
DisclosureSEC source: 0001923233-23-000083 · wk-form4_1701905860.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:45 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017626 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 17:27 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 2,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001923233-23-000025 · wf-form4_168253006607472.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,408 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 23:17 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | GrantCommon Stock, $0.0001 par value | 11,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004899 · form4-03142023_110329.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,401 F1 · shares: Represents 11,800 restricted share units ("RSUs") granted under the Agiliti, Inc. Amended and Restated 2018 Omnibus Incentive Plan, which vest on March 10, 2024, subject to the reporting person remaining a director of the issuer on the vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2022 Filed Apr 27, 2022 00:15 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 3,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001923233-22-000014 · wf-form4_165101848869859.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,958 Read SEC document |
| March 03, 2022 Filed Mar 8, 2022 02:02 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | GrantCommon Stock, $0.0001 par value | 8,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002709 · form4-03072022_060301.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,601 F1 · security: The reporting person received 8,672 restricted share units ("RSUs") under the Agiliti, Inc. Amended and Restated 2018 Omnibus Incentive Plan. The RSUs vest ratably on each of March 6, 2023, March 6, 2024 and March 6, 2025, subject to the reporting person remaining in continuous employment with the issuer on the vesting date. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 16:30 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001659154-21-000024 · wf-form4_161971382038209.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,726 Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:48 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | GrantCommon Stock, $0.0001 par value | 34,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-017426 · doc4.xml · nonDerivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,786 F2 · security: In connection with the issuer's initial public offering, the reporting person received 34,286 restricted share units ("RSUs") under the Agiliti, Inc. Amended and Restated 2018 Omnibus Incentive Plan. The RSUs vest ratably on each of March 6, 2022, March 6, 2023 and March 6, 2024, subject to the reporting person remaining in continuous employment with the issuer on the vesting date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 22:48 UTC | AGILITI, INC. \DE AGTI · Entity 91354 | PurchaseCommon Stock, $0.0001 par value | 7,500 | $14.00 | $105,000.00 |
DisclosureSEC source: 0000899243-21-017426 · doc4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · kind: The purchase reported in this Form 4 was effected pursuant to a directed share program held by the issuer in connection with its initial public offering. Read SEC document |
| April 27, 2021 Filed Aug 2, 2021 19:53 UTC Amendment | AGILITI, INC. \DE AGTI · Entity 91354 | GrantCommon Stock, $0.0001 par value | 11,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-098819 · tm2123768-1_4aseq1.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,929 F1 · security: On April 29, 2021, the reporting person filed a Form 4 which, due to an administrative error, reported the receipt of 34,286 restricted share units ("RSUs") under the Agiliti, Inc. Amended and Restated 2018 Omnibus Incentive Plan. In fact, the reporting person received 11,429 RSUs. This amendment corrects the error. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2020 Filed Apr 22, 2020 20:40 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 3,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001659154-20-000028 · wf-form4_158758803957919.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,059 Read SEC document |
| March 02, 2020 Filed Mar 2, 2020 22:46 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | PurchaseCommon Stock | 5,000 | $29.48 | $147,410.00 |
DisclosureSEC source: 0001659154-20-000014 · wf-form4_158318919454573.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,338 Read SEC document |
| March 02, 2020 Filed Mar 2, 2020 21:03 UTC | CONMED Corp CNMD · Entity 4691 | PurchaseCommon Stock | 2,000 | $94.63 | $189,264.00 |
DisclosureSEC source: 0001127602-20-008558 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,035 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:13 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020757 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2019 Filed Apr 30, 2019 22:50 UTC | FEDERAL SIGNAL CORP /DE/ FSS · Entity 3709 | GrantCommon Stock | 3,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001659154-19-000043 · wf-form4_155666461133219.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,338 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.